![]() |
Global incidence and prevalence of nonalcoholic fatty liver disease
Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah
Clin Mol Hepatol. 2023;29(Suppl):S32-S42. Published online 2022 Dec 14 DOI: https://doi.org/10.3350/cmh.2022.0365
|
Citations to this article as recorded by
Endogenous n-3 PUFAs Improve Non-Alcoholic Fatty Liver Disease through FFAR4-Mediated Gut–Liver Crosstalk
Xuan Jiang, Qin Yang, Hongyan Qu, Yongquan Chen, Shenglong Zhu
Nutrients.2023; 15(3): 586. CrossRef Editorial: clinical outcomes in lean NAFLD—the devil is in the details
Eunice X. X. Tan, Mark Dhinesh Muthiah, Cheng Han Ng, Daniel Q. Huang
Alimentary Pharmacology & Therapeutics.2023; 57(9): 1040. CrossRef Noninvasive Assessment of Liver Fibrosis in NAFLD
Arun J. Sanyal, Laurent Castera, Vincent Wai-Sun Wong
Clinical Gastroenterology and Hepatology.2023; 21(8): 2026. CrossRef Nonalcoholic fatty liver disease in polycystic ovary syndrome: Result of a single-center cross-sectional study in Bangladesh
HafejaAkhter Hima, MdAbdul Hannan Miah, NipaRani Ghosh, Sazia Sultana, Tanjina Akter, FatemaTuz Zahura Aalpona, AB. M. Kamrul-Hasan
Bangladesh Journal of Endocrinology and Metabolism.2023; 2(2): 80. CrossRef The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD
Ana Petrovic, Dunja Igrec, Karla Rozac, Kristina Bojanic, Lucija Kuna, Tea Omanovic Kolaric, Vjera Mihaljevic, Renata Sikora, Robert Smolic, Marija Glasnovic, George Y. Wu, Martina Smolic
Current Issues in Molecular Biology.2023; 45(6): 4544. CrossRef Close association of PFASs exposure with hepatic fibrosis than steatosis: evidences from NHANES 2017–2018
Wenli Cheng, Min Li, Luyun Zhang, Cheng Zhou, Xinyu Zhang, Chenyu Zhu, Luyi Tan, Hui Lin, Wenjuan Zhang, Wenji Zhang
Annals of Medicine.2023;[Epub] CrossRef Heterozygous midnolin knockout attenuates severity of nonalcoholic fatty liver disease in mice fed a Western-style diet high in fat, cholesterol, and fructose
Soo-Mi Kweon, Jose Irimia-Dominguez, Gayeoun Kim, Patrick T. Fueger, Kinji Asahina, Keith K. Lai, Daniela S. Allende, Quincy R. Lai, Chih-Hong Lou, Walter M. Tsark, Ju Dong Yang, Dominic S. Ng, Ju-Seog Lee, Patrick Tso, Wendong Huang, Keane K. Y. Lai
American Journal of Physiology-Gastrointestinal and Liver Physiology.2023; 325(2): G147. CrossRef Synergistic Preventive Effect of Aerobic and Resistance Exercises on Nonalcoholic Fatty Liver Disease
Ju-Yeon Cho, Won Sohn
Gut and Liver.2023; 17(4): 487. CrossRef Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments
Lucy Petagine, Mohammed Gulrez Zariwala, Vinood B Patel
World Journal of Gastroenterology.2023; 29(32): 4831. CrossRef Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
Yuan Yao, Yunfeng Shen
Open Life Sciences.2023;[Epub] CrossRef The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis
Pojsakorn Danpanichkul, Cheng Han Ng, Mark D. Muthiah, Kwanjit Duangsonk, Jie Ning Yong, Darren Jun Hao Tan, Wen Hui Lim, Zhen Yu Wong, Nicholas Syn, Tsubasa Tsusumi, Hirokazu Takahashi, Mohammad Shadab Siddiqui, Vincent Wai‐Sun Wong, Christos S. Mantzoro
Alimentary Pharmacology & Therapeutics.2023; 58(10): 1062. CrossRef Ameliorative Effects of Anthocyanin Metabolites on Western Diet-Induced NAFLD by Modulating Co-Occurrence Networks of Gut Microbiome
Hironobu Nakano, Kozue Sakao, Koji Wada, De-Xing Hou
Microorganisms.2023; 11(10): 2408. CrossRef Challenges and Solutions in the Management of Hepatocellular Carcinoma Associated with Non-Alcoholic Fatty Liver Disease
Ramona Cadar, Corina Lupascu Ursulescu, Alin Mihai Vasilescu, Ana Maria Trofin, Mihai Zabara, Delia Rusu-Andriesi, Bogdan Ciuntu, Cristina Muzica, Cristian Dumitru Lupascu
Life.2023; 13(10): 1987. CrossRef Uncovering the Cardiovascular Threat: A Comprehensive Examination of Liver Fibrosis and Subclinical Atherosclerosis in Non-alcoholic Fatty Liver Disease
Niketa Sharma, Swarupa Chakole, Bhushan Wandile
Cureus.2023;[Epub] CrossRef Unveiling the role of gut dysbiosis in non-alcoholic fatty liver disease
Pranali A. Jadhav, Asha B. Thomas, Rabindra K. Nanda, Sohan S. Chitlange
European Journal of Gastroenterology & Hepatology.2023; 35(12): 1324. CrossRef Decellularization Techniques for Tissue Engineering: Towards Replicating Native Extracellular Matrix Architecture in Liver Regeneration
Ishita Allu, Ajay Kumar Sahi, Meghana Koppadi, Shravanya Gundu, Alina Sionkowska
Journal of Functional Biomaterials.2023; 14(10): 518. CrossRef Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases
Yankai Wen, Lichun Ma, Cynthia Ju
eGastroenterology.2023; 1(2): e100020. CrossRef Exploring the underlying mechanisms of Ashitaba in the management of non-alcoholic fatty liver disease by integrating the analysis of transcriptomics and metabolomics
Huan Yang, Yunshan Li, Weihong Xu, Wenjuan Liu, Ying Xie
Frontiers in Medicine.2023;[Epub] CrossRef Assessment of melatonin’s therapeutic effectiveness against hepatic steatosis induced by a high-carbohydrate high-fat diet in rats
Davood Dorranipour, Fahimeh Pourjafari, Reza Malekpour-Afshar, Mohsen Basiri, Mehran Hosseini
Naunyn-Schmiedeberg's Archives of Pharmacology.2023;[Epub] CrossRef The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Balteanu, Ramona Cioboata, Alice Elena Ghenea, Suzana Danoiu, Ana-Maria Bumbea, Viorel Biciusca
Diagnostics.2023; 13(21): 3316. CrossRef Pegozafermin Is a Potential Master Therapeutic Regulator in Metabolic Disorders: A Review
Nadian N. Bailey, Stephen J. Peterson, Manish A. Parikh, Kaedrea A. Jackson, William H. Frishman
Cardiology in Review.2023;[Epub] CrossRef Pentadecanoic Acid (C15:0), an Essential Fatty Acid, Shares Clinically Relevant Cell-Based Activities with Leading Longevity-Enhancing Compounds
Stephanie Venn-Watson, Nicholas J. Schork
Nutrients.2023; 15(21): 4607. CrossRef Association or causation: still more questions than answers in early-onset gastrointestinal cancers
E. Fontana, I. Ben-Aharon
ESMO Gastrointestinal Oncology.2023; 1: 40. CrossRef The Role of Epigenetic Control of Mitochondrial (Dys)Function in MASLD Onset and Progression
Valerio Caputo, Giovanni Tarantino, Silvano Junior Santini, Giovanna Fracassi, Clara Balsano
Nutrients.2023; 15(22): 4757. CrossRef Unraveling the Connection between Fatty Liver Severity with Gender, Lifestyle, and Health Risks among Workers
Feng-Cheng Tang, Ren-Hau Li, Jui-Hua Huang
Nutrients.2023; 15(22): 4765. CrossRef Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care
Masato Yoneda, Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, Satoru Saito, Atsushi Nakajima
Gut and Liver.2023; 17(6): 843. CrossRef Association of five diet scores with severe NAFLD incidence: A prospective study from UK Biobank
Fanny Petermann‐Rocha, Fernanda Carrasco‐Marin, Jirapitcha Boonpor, Solange Parra‐Soto, Oliver Shannon, Fiona Malcomson, Nathan Phillips, Mahek Jain, Salil Deo, Katherine M. Livingstone, Sara E. Dingle, John C. Mathers, Ewan Forrest, Frederick K. Ho, Jill
Diabetes, Obesity and Metabolism.2023;[Epub] CrossRef Editorial: Interactions between NAFLD and cardiac conduction, structure and function: recent advances and treatments
Christiano Argano
Frontiers in Endocrinology.2023;[Epub] CrossRef
|